ScienceOpen: research and publishing network

For Researchers

Search
Advanced search

1

views

    

0

recommends

0

shares

Record: found
Abstract: found
Article: not found

Should Propranolol Remain the Gold Standard for Treatment of Infantile Hemangioma? A Systematic Review and Meta-Analysis of Propranolol Versus Atenolol.

Author(s): Tiffany Chen ¹ , Rachana Gudipudi ¹ , Shaun A Nguyen ¹ , William Carroll ¹ , Clarice Clemmens ¹

Publication date (Electronic): Mar 2023

Journal: The Annals of otology, rhinology, and laryngology

Publisher: SAGE Publications

Keywords: atenolol, beta-blocker, infantile hemangioma, propranolol

Read this article at

ScienceOpenPublisher PubMed

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

Although propranolol has been established as the gold standard when treatment is sought for infantile hemangioma, concerns over its side effect profile have led to increasing usage of atenolol, a beta-1 selective blocker.

Related collections

Author and article information

Journal

Journal ID (iso-abbrev): Ann Otol Rhinol Laryngol

Title: The Annals of otology, rhinology, and laryngology

Publisher: SAGE Publications

ISSN (Electronic): 1943-572X

ISSN (Print): 0003-4894

Publication date (Electronic): Mar 2023

Volume: 132

Issue: 3

Affiliations

[1 ] Department of Otolaryngology-Head and Neck Surgery, Medical University of South Carolina, Charleston, SC, USA.

Article

DOI: 10.1177/00034894221089758

PubMed ID: 35466712

SO-VID: 5d52bcc2-835d-4665-b2d8-8fe5d29cd138

History

Keywords: propranolol,infantile hemangioma,beta-blocker,atenolol

Data availability:

Keywords: propranolol, infantile hemangioma, beta-blocker, atenolol

Comments

Comment on this article

scite_

Cited by 2

See all cited by